INS and chronic kidney disease: The ADA has included eGFR ≥ 20 as a routinely recommended threshold, and more clinical evidence is needed on the safety of pre-dialysis CKD (eGFR < 15); the risk of diabetic ketoacidosis and urinary tract infection while co-administering insulin need to be cautioned.